[1]
|
Oguzhanoglu, A., Tülay, K., Ortaç, R. and Bülent, T. (2014) Cellular and Molecular Mechanisms in Liver Fibrogenesis. Archives of Biochemistry and Biophysics, 548, 20-37. https://doi.org/10.1016/j.abb.2014.02.015
|
[2]
|
任蓓蓓, 杨婧, 安文慧, 郑杰, 杨秋瑾. 瞬时弹性成像在慢性肝病中的临床应用进展[J]. 中国现代医药杂志, 2020, 22(2): 89-93.
|
[3]
|
沈斐斐, 陆伦根. 瞬时弹性成像技术在慢性肝病肝纤维化诊断中的应用进展[J]. 实用肝脏病杂志, 2016, 19(5): 620-623.
|
[4]
|
Weiskirchen, R. and Tacke, F. (2016) Liver Fibrosis: From Pathogenesis to Novel Therapies. Digestive Diseases, 34, 410-422. https://doi.org/10.1159/000444556
|
[5]
|
聂青和. 肝纤维化的逆转策略及研究现状[J]. 世界华人消化杂志, 2005, 13(10): 1165-1174.
|
[6]
|
沈鼎明. 肝纤维化的发生机制[J]. 中华肝脏病杂志, 2000, 8(4): 241.
|
[7]
|
黄艳, 黄成, 李俊. 肝纤维化病程中Kupffer细胞分泌的细胞因子对肝星状细胞活化增殖、凋亡的调控[J]. 中国药理学通报, 2010, 26(1): 9-13.
|
[8]
|
凌文武, 卢强, 邱婷婷, 罗燕. 肝纤维化的超声诊断应用进展[J]. 四川医学, 2017, 38(5): 585-588.
|
[9]
|
张悦, 粟兴洋, 谢静怡, 潘珏, 纪泛扑. 《欧洲肝病学会临床实践指南: 评估肝脏疾病严重程度及预后的无创检测(2021年更新)》摘译[J]. 临床肝胆病杂志, 2021, 37(11): 2550-2554.
|
[10]
|
Sebastiani, G., Ghali, P., Wong, P., Klein, M.B., Deschenes, M. and Myers, R.P. (2014) Physicians’ Practices for Diagnosing Liver Fibrosis in Chronic Liver Diseases: A Nationwide, Canadian Survey. Canadian Journal of Gastroenterology and Hepatology, 28, 23-30. https://doi.org/10.1155/2014/675409
|
[11]
|
杨二娜, 曹武奎. 肝纤维化无创诊断的研究进展[J]. 临床肝胆病杂志, 2017, 33(11): 2209-2213.
|
[12]
|
盖美茹, 张华珍, 程爱玲, 张国强. 肝纤维化血清学指标与病毒性肝炎肝功能损害程度的关系[J]. 中国全科医学, 2003, 6(10): 824-825.
|
[13]
|
李宝, 王登峰, 孙彦峰. 不同类型人群血清中肝纤维四项检测结果分析[J]. 临床医学研究与实践, 2020, 5(17): 105-106 + 109-109.
|
[14]
|
庄云英, 张海燕, 曾清芳. 慢性乙型肝炎肝纤维化的无创诊断研究进展[J]. 肝脏, 2021, 26(1): 84-87.
|
[15]
|
张波克, 周导, 朱俊, 等. 血清肝纤维化四项在肝豆状核变性肝硬化进展中的变化及临床价值[J]. 中国临床研究, 2020, 33(7): 900-903.
|
[16]
|
贾海英, 郭淑丽, 王玲玲, 黄睿, 黄国虹, 王昌敏. 血清肝纤维化指标在慢性乙型肝炎不同阶段中的对比分析[J]. 实验与检验医学, 2020, 38(6): 1077-1078 + 1103-1103.
|
[17]
|
赵佳强, 路佳益, 张振林. 对肝纤维化过程中相关指标的研究探讨[J]. 保健文汇, 2020(12): 226-227.
|
[18]
|
中华医学会肝病学分会, 中华医学会消化病学分会, 中华医学会感染病学分会. 肝纤维化诊断及治疗共识(2019年) [J]. 临床肝胆病杂志, 2019, 35(10): 2163-2172.
|
[19]
|
Wai, C.T., Greenson, J.K., Fontana, R.J., et al. (2003) A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients with Chronic Hepatitis C. Hepatology, 38, 518-526.
https://doi.org/10.1053/jhep.2003.50346
|
[20]
|
Giada, S., Alessandro, V., Maria, G. and Alfredo, A. (2007) Sequential Algorithms Combining Non-Invasive Markers and Biopsy for the Assessment of Liver Fibrosis in Chronic Hepatitis B. World Journal of Gastroenterology, 13, 525-531. https://doi.org/10.3748/wjg.v13.i4.525
|
[21]
|
Jin, W.W., Lin, Z.H., Xin, Y.N., Jiang, X.J., Dong, Q.J. and Xuan, S.Y. (2012) Diagnostic Accuracy of the Aspartate Aminotransferase-to-Platelet Ratio Index for the Prediction of Hepatitis B-Related Fibrosis: A Leading Meta-Analysis. BioMed Central, 12, Article No. 14. https://doi.org/10.1186/1471-230X-12-14
|
[22]
|
陆伦根, 曾民德. 肝纤维化的诊断和评估[J]. 中华肝脏病杂志, 2005, 13(8): 603-604.
|
[23]
|
Richard, K.S., Lissen, E., Clumeck, N., et al. (2006) Development of a Simple Noninvasive Index to Predict Significant Fibrosis in Patients with HIV/HCV Coinfection. Hepatology (Baltimore, Md.), 43, 1317-1325.
https://doi.org/10.1002/hep.21178
|
[24]
|
Kim, B.K., Kim, D.Y., Park, J.Y., et al. (2010) Validation of FIB-4 and Comparison with Other Simple Noninvasive Indices for Predicting Liver Fibrosis and Cirrhosis in Hepatitis B Virus-Infected Patients. Liver International, 30, 546-553. https://doi.org/10.1111/j.1478-3231.2009.02192.x
|
[25]
|
Cross, T.J., Rizzi, P., Berry, P.A., Bruce, M., Portmann, B. and Harrison, P.M. (2009) King’s Score: An Accurate Marker of Cirrhosis in Chronic Hepatitis C. European Journal of Gastroenterology & Hepatology, 21, 730-738.
https://doi.org/10.1097/MEG.0b013e32830dfcb3
|
[26]
|
Keyur, P. Giada, S. (2020) Limitations of Non-Invasive Tests for Assessment of Liver Fibrosis. JHEP Reports, 2, Article ID: 100067. https://doi.org/10.1016/j.jhepr.2020.100067
|
[27]
|
高楠, 杨若男, 孟真, 王万海. 无创肝纤维化检测结果与慢性乙型肝炎肝纤维化程度的相关研究[J]. 东南大学学报(医学版), 2019, 38(2): 269-273.
|
[28]
|
Lemoine, M., Shimakawa, Y., Nayagam, S., et al. (2016) The Gamma-Glutamyl Transpeptidase to Platelet Ratio (GPR) Predicts Significant Liver Fibrosis and Cirrhosis in Patients with Chronic HBV Infection in West Africa. Gut, 65, 1369-1376. https://doi.org/10.1136/gutjnl-2015-309260
|
[29]
|
王海莉, 贾因棠. APRI、GPRI、FIB-4在诊断慢乙肝肝脏纤维化及肝癌中的临床应用价值[J]. 山西医科大学学报, 2018, 49(6): 650-654.
|
[30]
|
Zhou, K., Gao, C.F., Zhao, Y.P., et al. (2010) Simpler Score of Routine Laboratory Tests Predicts Liver Fibrosis in Patients with Chronic Hepatitis B. Journal of Gastroenterology and Hepatology, 25, 1569-1577.
https://doi.org/10.1111/j.1440-1746.2010.06383.x
|
[31]
|
Forns, X., Ampurdanès, S., Llovet, J.M., et al. (2002) Identification of Chronic Hepatitis C Patients without Hepatic Fibrosis by a Simple Predictive Model. Hepatology, 36, 986-992. https://doi.org/10.1053/jhep.2002.36128
|
[32]
|
刘红虹, 福军亮, 洪智贤, 等. 肝纤维化血清学无创检测研究进展[J]. 传染病信息, 2021, 34(4): 347-352.
|
[33]
|
Kladney, R.D. (2000) GP73, a Novel Golgi-Localized Protein Upregulated by Viral Infection. Gene, 249, 53-65.
https://doi.org/10.1016/S0378-1119(00)00136-0
|
[34]
|
罗双艳, 钟丽坤, 张国, 蒋长秀, 宋怀宇. 血清高尔基体蛋白73、血清诊断模型APRI及声辐射力脉冲成像技术在慢性乙型肝炎患者肝纤维化程度评估中的价值[J]. 广西医学, 2020, 42(5): 525-528.
|
[35]
|
李佳娜, 郑瑞琦, 李娜, 胡玉琳. 高尔基体蛋白73的生物学特征及在肝纤维化和肝硬化中的诊断价值[J]. 临床肝胆病杂志, 2019, 35(6): 1361-1364.
|
[36]
|
李莉, 李淑敏, 张志涛, 赵杰. 血清学指标联合瞬时弹性成像对乙肝肝纤维化及食管静脉曲张程度的诊断价值[J]. 浙江医学, 2019, 41(1): 63-66.
|
[37]
|
刘芳, 魏琳, 王珊珊, 黄斌. 瞬时弹性成像技术联合血清学指标对慢性乙型肝炎肝纤维化的诊断价值研究[J]. 中国全科医学, 2016, 19(25): 3039-3044.
|